NCT05563090

Brief Summary

The investigators aim to objectively identify the Traditional Chinese Medicine (TCM) syndrome differentiation of type II diabetic and prediabetic patients in Singapore through modern technologies thereby potentially increasing the accuracy of identification, diagnosis, and prevention of diabetes and prediabetes through a system of targeted treatment. This observational study integrates the concept of TCM diagnostic methods with modern tools aim to provide an objective view on the syndrome differentiation of diabetic and prediabetic patients in Singapore and hence provide a guideline in the treatment options targeted specifically at Singaporeans demographic. A total of 250 subjects with 50 allocated in each group will be recruited to ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation. Subjects aged 21-65 years old, of either gender, with no limitations on race, and is diagnosed with either diabetes (FPG ≥ 7.0 mmol/L, or 2hPG ≥ 11.1mmol) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L) will be included. Subjective and objective assessments through health evaluation, Physical Activity Questionnaire and Sugar Intake, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis and tongue diagnosis will be performed for each subject in a single visit. Statistical analysis of assessments will be conducted using unpaired t-test with significance level of p\<0.05. Statistical software SPSS 15.0 (SPSS Inc.) will be used for the analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 25, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 3, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

May 4, 2025

Status Verified

December 1, 2023

Enrollment Period

2.5 years

First QC Date

September 25, 2022

Last Update Submit

April 30, 2025

Conditions

Keywords

Diabetes MellitusType II diabetesPre-diabetesHealthy subjectshypertensiondyslipidemiaTCMTCM diagnosisPulse diagnosisTongue diagnosis

Outcome Measures

Primary Outcomes (4)

  • The Constitution in Chinese Medicine Questionnaire (CCMQ)

    The CCMQ, published by the China Association of Chinese Medicine in 2009, will be adopted to assess the body constitution of each subjects based on TCM principles \[26\]. Refer to Annex 3. There are nine different types of body constitution, including (a) Normality; (b) Qi deficiency; (c) Yin deficiency; (d) Yang deficiency; (e) Phlegm-dampness; (f) Damp-heat; (g) Blood stasis; (h) Qi depressed; (i) Inherited special constitution. Each subject will answer seven to eight questions in each category. The scoring algorithm indicates the likelihood of a specific type of body constitution with a higher score.

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Physical Activity Questionnaire and sugar intake

    Level of physical activity related to the last three months will be recorded through the Physical Activity Questionnaire. Sugar intake includes sweet or carbonated drinks, desserts like chocolates and cakes, 0 - 2, 3 - 6, or more than 7 times a week will also be recorded. Refer to Annex 2. This will help to identify the risk factors involved and identify the correlation between the body constitutions and various types of 'xiao-ke' based on TCM syndrome differentiation.

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Pulse sphygmograph

    The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Asia Plus Bio Tech Co., Ltd, Taiwan) would be used in the identification of RPPW of the subjects in this study. The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Figure 11) is a noninvasive device that consist of a high precision pressure sensor pen and a pulse analyzer. The 3D pulse detector is a handheld pen that digitalizes the biological signal of RPPW and provides a graphical analysis. The electronic device contains a high precision pressure sensor, a filter, an amplifier, and a signal recording card connected to signal analysis software. The frequency response is 0.1-50 Hz, and the sampling rate is 3000 Hz.

    One-time assessment within 30mins after undergoing the questionnaires

  • Tongue imaging device

    China Artificial Intelligence Health Status Identification System Model Number YZKJ-SMZY-1AI (Figure 12) will be used in the imaging and analysis of the subject's tongue. The noninvasive device captures the image of the tongue through an inbuilt camera supported by LED lights within the device. A monitor that is connected to the imaging device would provide a live video feedback on the positioning of the tongue. The images of the subjects' face, tongue, and sublingual collaterals will then be compared and analyzed for the similarities against standard images of tongue analysis using an artificial intelligence system.

    One-time assessment within 30mins after undergoing the questionnaires

Secondary Outcomes (10)

  • Health Evaluation - Age

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Health Evaluation - Gender

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Health Evaluation - Weight

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Health Evaluation - Height

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • Health Evaluation - BMI

    One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.

  • +5 more secondary outcomes

Study Arms (5)

0HEA

Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

1PRE

Prediabetes with IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

2DIA

Diabetes with FPG of ≥ 7.0 mmol/L, 2hPG of ≥ 11.1mmol, or HbA1c of \> 6.5%

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

3PREHD

Prediabetes with hypertension and dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

4DIAHD

Diabetes with hypertension and dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

Interventions

Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

0HEA1PRE2DIA3PREHD4DIAHD

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subjects need to be at 21-75 years old, of either gender, with no limitations on race, and is clinically diagnosed by Western medical doctors with either diabetes (FPG of ≥ 7.0 mmol/L, 2hPG of ≥ 11.1mmol, or HbA1c of \> 6.5%) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L). Healthy or sub-healthy subjects without any significant health related issues, eg. clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia, will be recruited as the control group. The health evaluation form (Annex 1) will be used to verify that these healthy subjects (1) do not have any family history of diabetes, and (2) do not have unusual high fasting blood glucose detected within one year.

You may qualify if:

  • Aged 21-75 years old, inclusive;
  • Clinically diagnosed with one of the following:
  • Type II Diabetes Mellitus with or without hypertension and dyslipidemia
  • Prediabetes with or without hypertension and dyslipidemia
  • Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia

You may not qualify if:

  • Subjects diagnosed with Gestational Diabetes
  • Subjects who are pregnant or lactating
  • Subjects with chronic heart failure, history of carcinomas with treatment of chemotherapy/radiotherapy, psychological, or psychiatric disorders
  • Subjects with heart diseases and transplanted devices such as pacemakers;
  • Subjects with acute infections such as upper respiratory infections, acute gastroenteritis, or urinary tract infections;
  • Subjects unable to undergo evaluation with the pulse sphygmograph, tongue detection or complete the questionnaire;
  • Subjects with communication disorders
  • Subjects with gastroenterology diseases or are diagnosed with 'spleen and stomach deficiency' (脾胃虚弱)
  • Subjects undergoing TCM treatment for diabetes or pre-diabetes within 1 week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore Chung Hwa Medical Institution

Singapore, 319522, Singapore

Location

Related Publications (1)

  • Ng HP, Chong SY, Li YH, Goh TH, Pang KY, Pereira MJ, Huang CM. Objective Analysis of Traditional Chinese Medicine Syndrome Differentiation of Patients With Diabetes and Prediabetes: Protocol for a Nonrandomized, Exploratory, Observational Case-Control Study Using Digitalized Traditional Chinese Medicine Diagnostic Tools. JMIR Res Protoc. 2024 Sep 12;13:e56024. doi: 10.2196/56024.

MeSH Terms

Conditions

Diabetes MellitusGlucose IntoleranceHypertensionDiabetes Mellitus, Type 2Dyslipidemias

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemiaVascular DiseasesCardiovascular DiseasesLipid Metabolism Disorders

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2022

First Posted

October 3, 2022

Study Start

September 17, 2022

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

May 4, 2025

Record last verified: 2023-12

Locations